Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H33N2O2 |
| Molecular Weight | 273.4347 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SMILES
CCCCN(CCCC)C(=O)OCC[N+](C)(C)CC
InChI
InChIKey=SDEXVKFYBBHUKN-UHFFFAOYSA-N
InChI=1S/C15H33N2O2/c1-6-9-11-16(12-10-7-2)15(18)19-14-13-17(4,5)8-3/h6-14H2,1-5H3/q+1
| Molecular Formula | C15H33N2O2 |
| Molecular Weight | 273.4347 |
| Charge | 1 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DIBUTOLINE, an antispasmodic drug, produces paresis of smooth muscles innervated by the parasympathetic nervous system. Its effect on the smooth muscles, therefore, simulates that of paralysis of the oculomotor nerve, that is, paresis of the sphincter of the iris and the ciliary muscles. DIBUTOLINE has no effect on the ocular muscles innervated by the sympathetic nervous system.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:10 GMT 2025
by
admin
on
Mon Mar 31 17:45:10 GMT 2025
|
| Record UNII |
1B3Q705AQH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID90176369
Created by
admin on Mon Mar 31 17:45:11 GMT 2025 , Edited by admin on Mon Mar 31 17:45:11 GMT 2025
|
PRIMARY | |||
|
10764
Created by
admin on Mon Mar 31 17:45:11 GMT 2025 , Edited by admin on Mon Mar 31 17:45:11 GMT 2025
|
PRIMARY | |||
|
21962-82-3
Created by
admin on Mon Mar 31 17:45:11 GMT 2025 , Edited by admin on Mon Mar 31 17:45:11 GMT 2025
|
PRIMARY | |||
|
1B3Q705AQH
Created by
admin on Mon Mar 31 17:45:11 GMT 2025 , Edited by admin on Mon Mar 31 17:45:11 GMT 2025
|
PRIMARY |